A mother's obesity can cause malformations in her children

July 16, 2004

This release is also available in Spanish

A study of more than 2000 children of women with gestational diabetes (the diabetes that some women get during pregnancy) has revealed that obesity in mothers is one of the most decisive factors contributing to the appearance of congenital malformations in their children, even more so than the seriousness of the diabetes. The research, published in the journal Diabetologia, has been carried out by a research team from the Universitat Autònoma de Barcelona and l'Hospital de Sant Pau in Barcelona.

It has been known since the 1960s that children of women with diabetes before pregnancy have a higher possibility of having congenital malformations, which are primarily related with the mother's degree of hyperglycemia (high blood sugar) during the period in which the embryo's organs are forming. In the children of women with gestational diabetes, which is first detected during pregnancy, the risk of malformations does not increase so much, but it still exists. In this case, during the period when the embryo's organs are forming the glucose levels are usually fairly unaltered.

A research team from the Universitat Autònoma de Barcelona and the Hospital de Sant Pau headed by Doctor Rosa Corcoy have come to an unexpected conclusion after analysing the relationship between the mother's glucose levels and congenital malformations in the children of mothers with gestational diabetes. Surprisingly, the body mass index, which indicates obesity, is more important for predicting malformations than other variables that indicate the seriousness of the maternal diabetes mellitus.

In a study of 2060 children, the researches decided to include the body mass index as a variable for the statistical analysis now that it has been demonstrated that obesity plays a part in congenital malformations in embryos, especially those related to the heart and the central nervous system. According to the study's results, the mother's degree of obesity is the main predicting factor for cardiac malformations and minor malformations, and the only factor able to predict renal and urinary tract malformations. The seriousness of the mother's gestational diabetes, however, was the only factor that could predict skeletal malformations.

Previous studies have not identified the degree of obesity as contributing to the risk of cardiac malformations in the children of woman with gestational diabetes, possibly because this variable wasn't included in the statistical analysis.

The authors of the study suggest two possible explications for obesity's important role in congenital malformations. Obesity is an indicator of energy availability and of all the nutrients that provide energy; the excess of these nutrients, and not only glucose, is linked with the appearance of malformations. In addition, both the excess and deficiency of insulin can provoke malformations in the embryo, and in the case of obesity, the fact that there is a resistance to the effects of the insulin results in higher concentrations.
-end-


Universitat Autonoma de Barcelona

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.